Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Late phase 2 study of OPC-12759 ophthalmic suspension in dry eye disease
jRCT2080220394Phase 2
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of rebamipide in dry eye syndrome (DED), sponsored by Otsuka Pharmaceutical Co., Ltd.
02
Drugs
rebamipide
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on jRCT2080220394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220394.